Table 2.
Variables | n | % | 5-year OS | P * | HR | 95% CI |
---|---|---|---|---|---|---|
Complete blood count | ||||||
White blood cell, No. | 0.32 | |||||
Low (≤7) | 125 | 39 | 62% | ref. | ||
High (>7) | 194 | 61 | 55% | 1.17 | (0.86 – 1.59) | |
Neutrophil, % | 0.26 | |||||
Low (≤77) | 264 | 83 | 60% | ref. | ||
High (>77) | 55 | 17 | 45% | 1.24 | (0.85 – 1.79) | |
Neutrophil, No. | 0.92 | |||||
Low (≤4) | 84 | 26 | 57% | ref. | ||
High (>4) | 235 | 74 | 58% | 1.02 | (0.72 – 1.43) | |
Lymphocyte, % | 0.005 | |||||
Low (≤15) | 71 | 22 | 38% | ref. | ||
High (>15) | 248 | 78 | 63% | 0.62 | (0.45 – 0.87) | |
Lymphocyte, No. | 0.26 | |||||
Low (≤2) | 257 | 81 | 55% | ref. | ||
High (>2) | 62 | 19 | 69% | 0.80 | (0.54 – 1.18) | |
Neutrophil/lymphocyte ratio | 0.001 | |||||
Low (≤5.5) | 266 | 83 | 62% | ref. | ||
High (>5.5) | 53 | 17 | 34% | 1.82 | (1.26 – 2.62) | |
Histologic inflammation scores | ||||||
Acute inflammation, % | 0.013 | |||||
Low (<5%) | 212 | 64 | 60% | ref. | ||
High (≥5%) | 119 | 36 | 53% | 1.46 | (1.08 – 1.97) | |
Chronic inflammation, % | 0.71 | |||||
Low (<10%) | 196 | 59 | 59% | ref. | ||
High (≥10%) | 135 | 41 | 56% | 1.06 | (0.79 – 1.42) | |
Lymph follicles, No. | 0.041 | |||||
Low (<5) | 188 | 57 | 62% | ref. | ||
High (≥5) | 143 | 43 | 52% | 1.35 | (1.01 – 1.81) |
P-values adjusting for pathologic stage. Significant P-values are shown in bold.
OS, overall survival; HR, hazard ratio; CI, confidence interval